Both in Diagnostics
Celldex Therapeutics vs Intellia Therapeutics
Over the past year CLDX returned +25.5% and NTLA returned +0.9%; their daily moves had a correlation of 0.33.
CLDX +25.5% NTLA +0.9%Growth of $1, one year, split-adjusted
| Metric | CLDX | NTLA |
|---|---|---|
| Price | $29.93 | $12.31 |
| Market cap | $2.35B | $1.72B |
| Today | +0.74% | +3.79% |
| 1 month | −3.5% | −0.5% |
| 6 months | −13.0% | −11.1% |
| Year to date | +10.2% | +36.9% |
| 1 year | +20.9% | −5.8% |
| Revenue growth (YoY) | −97.0% | −46.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −334104.5% | −1392.3% |
| P/E (TTM) | — | — |
| Price / sales | 14,875.9× | 29.0× |
| Net cash | $717.6M | $437.8M |
| Dividend yield | — | — |
| Volatility (60d) | 47.7% | 63.0% |
| Short % of float | 13.0% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).